Provocation After Nurse-Directed Assessment (PANDA) Study
Recruiting now
Conditions studied: Drug Allergy, Penicillin Allergy
In brief
The study aims to evaluate the effectiveness and safety of a collaborative nurse-allergist approach in penicillin allergy delabeling services. It also seeks to assess the impact on patients' quality of life and compare resource utilization and cost-effectiveness between the nurse-allergist collaborative approach and the traditional allergist-led approach.
Key facts
- Study ID
- NCT07127835
- Run by
- The University of Hong Kong
- People needed
- 440
- Starts
- 2025-09-01
- Expected to finish
- 2029-08-31
- Last updated by the study team
- 2026-04-29
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Receiving inpatient or outpatient treatment at a participating hospital during the study period;
- Possessing a documented penicillin allergy label;
- Underwent penicillin allergy evaluation by the nurse-allergist collaborative approach or the traditional allergist-led approach
- Demographic and clinical data required for the study available.
You may not qualify if…
- Patients unable to provide a complete medication history or history of penicillin allergy;
- Patients with only emergency or short-term treatment records;
- Patients who have taken steroids, antihistamines, or similar medications within the last 3 days.
Where it is running
- Prince of Wales Hospital — Hong Kong, Hong Kong (enrolling)
- Princess Margaret Hospital — Hong Kong, Hong Kong (enrolling)
- Queen Elizabeth Hospital — Hong Kong, Hong Kong (enrolling)
- Queen Mary Hospital — Hong Kong, Hong Kong (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.